Renal transplant recipient
Clinical trials for Renal transplant recipient explained in plain language.
Never miss a new study
Get alerted when new Renal transplant recipient trials appear
Sign up with your email to follow new studies for Renal transplant recipient, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Kidney transplant patients may swap monthly IV for weekly shots in new study
Disease control CompletedThis phase 2 trial tests whether kidney transplant patients can safely switch from monthly belatacept IV infusions to weekly abatacept injections without losing kidney function. The study enrolls 87 low-risk adults who are at least two years post-transplant. Researchers will comp…
Matched conditions: RENAL TRANSPLANT RECIPIENT
Phase 2 • Sponsor: Emory University • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Kidney transplant breakthrough: could this be the end of lifelong pills?
Disease control CompletedThis early-stage study tested a new approach to help kidney transplant recipients stop taking anti-rejection drugs. Eight adults received donor stem cells along with a special mix of medications to see if their bodies would accept the new kidney without needing lifelong drugs. Th…
Matched conditions: RENAL TRANSPLANT RECIPIENT
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC